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1. Introduction 
Atherosclerosis, with its complications, is the most frequent cause of death all over the 
world, and it is the underlying cause of about 50% of all deaths in developed countries (1). 
Recent studies showed the key role played by inflammation and immune responses in 
development, progression, and rupture of atherosclerotic plaque (2,3,4). The presence of an 
immune reaction and/or infective antigens as potential triggers of atherogenesis (5,6) makes 
atherosclerosis be considered as an autoimmune disease in which the adaptive immune 
system is targeted against self-antigens modified by biochemical factors such as oxidative 
stress and hypercholesterolemia (7). These give rise to plaque birth (8,9) and the 
inflammatory status of the plaque makes the lesions unstable, inducing their abruption and 
acute thrombotic obstruction. Therefore, it induces impairment in endothelial function in 
bioactive antiatherogenic or proatherogenic molecules production (10), although other 
factors could increase such an imbalance: age (11), sex (12), hypertension (13), obesity (14), 
smoking (15), dyslipidemia (16), diabetes (17), all able to increase oxidative stress and 
vascular inflammation (18), morphological wall alterations and subsequently progression of 
atheromatous lesions. 
The initial atherosclerosis stages silently and symptom free occur since childhood (19); the 
clinical expressions (i.e., sudden cardiac death, myocardial infarction, angina pectoris, 
stroke, aortic aneurysm, renovascular hypertension, and intermittent claudication) involve 2 
over 3 men and 1 over 2 women after age 40, and almost 60% of deaths are due to a 
cardiovascular disease cause (20). Thus, there has been an increase in recognition of the 
importance of subclinical atherosclerosis, and early detection of this insidious process must 
be the goal for improving cardiovascular health through prevention, and treatment of risk 
factors. 
Currently, non-invasive risk profile assessments can be evaluated not only with some 
laboratory parameters, (lipids and systemic inflammation markers as white blood cells, 
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reactive C protein and erythrocyte segmentation rate), but also with ultrasonographic 
methods that detect subclinical atherosclerosis. Three internationally validated methods had 
been adopted in order to evaluate endothelium function: brachial artery flow-mediated 
vasodilation (FMD) (21,22), antero-posterior abdominal aorta diameter (APAO) (23) and 
intima-media thickness of the common carotid artery (CCA-IMT) (24,25). Cause of their 
non-invasiveness, feasibility and cheap cost, these techniques are the best tools for the 
physicians to assess functional and morphological alterations of the arteries before a 
cardiovascular event occurs and the feasibility of therapies to reduce atherosclerosis burden 
(26). 
2. FMD technique 
The endothelium is a real “organ”, endowed with autocrine and paracrine properties and 
playing an essential role in controlling vasomotion by producing molecules able to modulate 
blood, such as nitric oxide (NO), the most important vasodilator molecule produced by 
endothelial cells) (27). Shear stress is the main element able to determine increasing in NO 
production, its action being exerted perpendicularly to the long axis of the vessel. 
Nevertheless, endothelial cells can also produce substances with vasoconstrictor action, as 
endothelin-1, (27) above all in case of increased age, hyperhomocysteinemia, smoking, 
diabetes, hypercholesterolemia, and hypertension (28): in these case it could be detected the 
presence of reduced vasodilating response to endothelial stimuli. Instead, diet and exercise 
can improve endothelial function (29). Lipid-lowering therapy (30,31), antioxidants (32), 
estrogen replacement (33) and treatment with angiotensin-converting enzyme inhibition or 
receptor blockade (34) improve this response. 
Thus, endothelial dysfunction is considered the basic pathogenic mechanism of 
cardiovascular disease (35) and therefore can be considered as an early marker of 
cardiovascular risk. 
In fact, the endothelial dysfunction seems to be the earliest event in the process of 
atherosclerotic plaque formation, appearing even before structural lesion of the vessel wall 
(36); for this reason the evaluation of endothelial function could be a useful tool for early 
stratification of patients at risk for cardiovascular events. 
Studies in postmenopausal women suggest that endothelial dysfunction may be a 
predisposing factor for the development of hypertension (37) and diabetes (38), thus being 
not only a consequence of risk factors but also a pathogenetic mechanism for their onset. 
Moreover, impaired endothelium-dependent vasomotion may contribute to the genesis of 
cardiovascular events by modulating the stability of plaque and coronary vasospasm. In 
fact, the analysis of Lerman and Zeiher (39) showed that endothelial dysfunction, assessed 
both at coronary and peripheral level, is significantly predictive of cardiovascular events 
independently of the presence of traditional cardiovascular risk factors. 
3. Procedure description 
A non-invasive method to assess endothelium-dependent flow-mediated vasodilation 
(FMD) was developed in the 1990s: it consisted in inducing endothelial cells to release NO 
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(40,41) through mechanical stimulation originating from increasing in vessel wall “shear 
stress”. It is usually performed at brachial artery level by high-frequency ultrasonographic 
imaging (21). 
It is performed in a quiet, temperature-controlled (22–24°C) room, early in the morning and 
it adopts a high resolution ultrasonograph connected to an image analysis system and a 
sphygmomanometer cuff applied around the forearm to create a flow stimulus in the 
brachial artery. The examination requires the patients to be supine, at rest, fast for at least 8 
to 12 hours before the study; all vasoactive medications (calcium channel blockers, ß-
adrenergic blocking agents, nitrates and converting enzyme inhibitors) should be withheld 
for at least 4 half-lives, if possible. Moreover, subjects should avoid substances that might 
impair FMD such as caffeine, high-fat foods, and vitamin C or use tobacco for at least 4 to 6 
hours before the study (table 1). 
FACTORS COMMENTS 
Hours The examination should be performed at the same time of day 
Temperature Ultrasonographic evaluation should be performed at constant 
temperature, in an environment equipped with air 
conditioning 
Drugs All vasoactive drugs should be discontinued the night before 
the exam 
Coffee and The The day of the examination, the patient should refrain from 
taking coffee or tea 
Smoking Patients should abstain from smoking 
Influence of food Patients should not take copious meals or high in fat 
Brachial artery diameter It must be between 2.5 and 5 mm 
Table 1. Prerequisites and factors that influence the flow-mediated dilation 
The 7,5 MHz electronic probe is positioned 4–5 cm above ante-cubital fossa to obtain 
longitudinal B-mode vascular scanning of the brachial artery with clear anterior and 
posterior intimal-lumen interfaces, and once the optimal artery image is achieved, the probe 
can be maintained in the right position using a mechanical arm. A pulsed wave Doppler 
recording is obtained from the midartery. 
The procedure lasts 9 minutes: the first minute evaluate baseline diameter, measured at the 
onset of the R-wave on the electrocardiogram. 
At the end of the first minute, the cuff is inflated 200-250 mmHg in order to close arterial 
inflow of the forearm (42). This causes ischemia and, consequentially, dilation of 
downstream resistance vessels by autoregulatory mechanisms. 
After the sixth minute, the cuff is rapidly deflated: a brief high-flow state through the 
brachial artery to accommodate the dilated resistance vessels happens, and this reactive 
hyperemia produces a shear stress stimulus that induces the endothelium to release nitric 
oxide with subsequent vasodilation of the brachial artery between the 6th and 9th minute. 
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The software calculates FMD value as percentage of increasing of diameter value from 
baseline: 
FMD = [(postiperemia diameter - baseline diameter) / baseline diameter] x 100 
The maximal increase in diameter occurs approximately 60 to 90 seconds after cuff release. 
FMD values greater than 5-10% are considered “normal” (21). A schematic overview of this 
imaging technique could be observed in figure 1a. 
This reactive hyperemia phase is confirmed by measuring the arterial blood flow using 
pulse-wave Doppler. The peak blood flow in the brachial artery is obtained with the sample 
volume in the centre of the artery and a correction angle of 70°. It is estimated at rest and 
during the first 15 s after cuff deflation, taking the average of the pulsed Doppler velocity 
signal of 3 measurements. The maximum speeds considered normal is 50–70 cm/s. Reactive 
hyperemia is calculated as the ratio of the maximal velocity divided by the maximal velocity 
at baseline.  
Because of its low reproducibility and accuracy (43,44), the technique requires very high 
methodology accuracy and a mechanical support for the probe with micrometer adjustment 
to prevent movement of the vascular probe, and specific software ("FMD Studio") to 
measure second to second changes in artery caliber (21). The variations in caliber measured 
are small (from 0 to 15%), so the FMD represents a stimulus-type “on / off” poorly 
modulated. 
Therefore, in order to obtain results that have a clinical validity, it is necessary to study a 
large number of patients. In support of the role of endothelial function as marker of 
cardiovascular risk and of the validity of the FMD method, there is also correlation with the 
invasive test data of coronary endothelial function (45) and with the severity and extent of 
atherosclerosis coronary (46).  
Moreover, the noninvasive nature of the technique allows repeated measurements over time 
to study the effectiveness of various interventions that may affect vascular health.  
4. APAO 
Up to now the infrarenal anteroposterior diameter of abdominal aorta (APAO) has been 
always related to the abdominal aortic aneurysms (AAAs), as a measurement to be used in 
the diagnostic and follow-up phase of this disease and for surgical intervention planning. 
An abdominal aortic aneurysm is defined by some authors as an infrarenal aortic diameter ≥ 
3.0 cm, or a ratio between infrarenal and suprarenal aorta diameters greater than 1.2, all 
measured by ultrasound B-mode (47). As coronary heart disease and stroke continue to be 
the leading causes of death and disability among adults in developed countries, an early 
detection of vascular damage and, consequently, adequate cardiovascular risk stratification 
has received an intense attention in the last years in order to decrease the impact of 
cardiovascular disease. 
To detect the “primum movens” of atherosclerotic disease, several studies have been 
conducted in the last years for identify new ultrasonographic markers (48). 
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Intima-media thickness of abdominal aorta has been firstly suggested as cardiovascular risk 
marker in patients stratification risk profile (49). 
Recently, in addition to arterial wall thickening, attention has been paid on APAO as a 
possible early marker of atherosclerosis (before clinical manifestations have become 
evident). Indeed, arterial dilatation is a well-known age-related manifestation, and some of 
the molecular events causing this alterations are involved in the pathogenesis of 
cardiovascular disease (50,51).  
There is a relationship between APAO in the non-aneurysmal range (<30 mm in diameter) 
and all-cause mortality: in a cohort of 12203 men aged 65 years and older infrarenal aortic 
diameter is turned out to be an independent predictor of all-cause mortality, particularly 
cardiovascular mortality (52). In another study on 4734 participants > 65 years old 
underwent to abdominal aortic ultrasound evaluation, has been demonstrated that for those 
with an infrarenal aortic diameters >2.0 cm, there was a significantly higher risk of future 
cardiovascular events and total mortality, suggesting a value of infrarenal aortic diameters 
between 2.0 and 3.0 cm as another manifestation of subclinical atherosclerosis (53).  
Furtheremore, Allison et al (54) showed that age, gender, body mass index, and the presence 
and extent of calcified atherosclerosis in both the abdominal aorta and iliac arteries are 
significantly associated with increasing aortic diameter independently of other cardiovascular 
risk factors. A study by Ciccone et al. involving women with polycystic ovary syndrome PCOS 
(55) showed that the increase in APAO is the earliest arterial alteration in women with PCOS, 
thus preceding the IMT of other arteries such as common carotid arteries and common femoral 
arteries. This identifies APAO as an early marker of atherosclerosis.  
However, this alteration seems to be due to body weight secondary to PCOS and not to 
PCOS per se. In fact, Gorter PM et al (56) showed that intra-abdominal fat accumulation and 
metabolic syndrome are associated with larger infrarenal aortic diameter in patients with 
clinically evident arterial disease, indicating a role for intra-abdominal fat in the 
development of larger aortic diameters. 
To explain these findings it can be hypothesized that APAO may represent a measure of 
cumulative exposure to genetic and environmental risk factors implicated in atherosclerosis 
development. For these reasons, APAO can be considered as an early marker of 
cardiovascular risk, and because of its noninvasive measurement and feasibility might be 
used to investigate determinants of atherosclerosis at an early stage of the process and to 
assess modifiers of atherosclerosis disease progression, such as lifestyle and 
pharmacological interventions. 
5. Procedure description 
Wilmink and colleagues (57,58) showed that the use of ultrasounds to measure the 
infrarenal aortic diameter is attractive as it is rapid, cheap, and noninvasive. The good 
accuracy of infrarenal aortic diameter measurements by ultrasound makes this method 
acceptable for clinical decision-making.  
With the patient in supine position, the examination is carried out with a 3.5 MHz electronic 
probe placed one centimetre left of the umbilicus. The longitudinal ultrasound scans allow the 
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study of the aorta and the best image in long axis projection of the abdominal aorta is used for 
the measurement. To improve the image acquisition, subjects are asked to keep fasting for at 
least 6-8 hours and follow a fiber diet for the two days prior to the examination to reduce 
intestinal bloating (diet preparation). To reduce the bias and interobserver variability the study 
of infrarenal abdominal aorta should be performed by same physician (59,60).  
In the study of Ciccone et al.(55) the anteroposterior diameter of the aorta was defined as the 
maximal external cross-sectional measurement. It was calculated as the distance between the 
near and the far walls of the abdominal aorta on images that were frozen in systole. All the 
measurements were performed at 0.5, 1, and 2 cm above the umbilicus and were expressed 
in centimetres (see also Figure 1c and 1d). 
 
Fig. 1. a) Flow-mediated vasodilation (FMD) technique image. b) Ultrasound evaluation of 
common carotid artery intima-media thickness. c) Antero-posterior abdominal aorta 
diameter in long axis views. d) Antero-posterior abdominal aorta diameter in short axis 
views 
However, in several studies the position of the probe and the part of abdominal aorta 
evaluated may be different. 
van den Bosch et al. (61) studied distal aortic diameter to assess the relationship between 
abdominal aortic diameter and peripheral arterial occlusive disease. They demonstrated that 
both patients with an aortic diameter too large and patients with an aortic diameter too 
small are prone to peripheral arterial occlusive disease. 
The study of Norman P. et al. (52) was carried out using a 3.75 mol/L Hz probe to measure 
the maximum transverse and antero-posterior diameter of the infrarenal aorta. The largest 
measurement was recorded as the aortic diameter. 
Pleumeekers et al. (62) evaluated the observer variability of ultrasound measurements of 
proximal and distal part of the abdominal aorta. Their results were that ultrasound 
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measurements are more accurate for the distal than for the proximal aorta measurement and 
the definition of the aortic diameter based on a combination of both distal and proximal 
measurement may be more accurate. 
6. IMT 
Atherosclerosis is a disease with a slowly progressive course and a long asymptomatic 
period. The clinical manifestations generally appear in middle age (63), and the first event 
triggered by atherosclerosis can be fatal. 
Since the atherosclerotic disease is a multidistrict and multifocal process, identifying the 
changes of the vascular wall at subclinical stages of atherosclerosis is essential in assessing 
global cardiovascular risk (64) and in promoting the use of preventive strategies, as well as 
optimization of preventive and protective care. 
Among imaging techniques for detection of early preclinical stages of atherosclerosis, the 
best is the measurement of the carotid intima-media thickness (CCA-IMT) using ultrasound 
high-resolution B-mode; the evaluation of this parameter is a noninvasive and reproducible 
method for identifying and quantifying subclinical vascular disease. 
It is a well-validated research tool that has been translated increasingly into clinical practice 
as a cardiovascular risk marker (65,66). 
Many studies demonstrated the role of CCA-IMT in the early evaluation of atherosclerosis 
disease. In fact, this parameter was found to be associated with the presence of 
cardiovascular risk factors (67,68,69) and with atherosclerotic lesions in other vascular 
districts, such as coronary and lower extremity arteries (70,71,72). Gasparyan (73) already 
put on evidence the importance of carotid ultrasound assessment in the clinical practice. 
Apart from CCA-IMT evaluation, the ultrasound evaluation should consider all the 
characteristics of carotid wall: it is necessary to evaluate IMT and, at the same time, 
morphological aspects of carotid wall. 
Prospective epidemiological studies showed that individuals with elevated carotid IMT are 
more likely to suffer from cardiovascular or cerebrovascular events, suggesting that 
thickened carotid IMT is a powerful and independent indicator of the likelihood of general 
arteriosclerosis (74,75). The predictive power of carotid IMT is maintained even after 
adjustment for major cardiovascular risk factors. Thus, measurement of IMT may provide 
informations in addition to traditional risk factors during assessment of global 
cardiovascular risk profile in asymptomatic subjects (76). 
SSeveral works in the last decade confirmed the role of this parameter in the early detection 
of atherosclerosis and in measure of its severity (77,78). 
Moreover, changes in carotid IMT may be used as a measure of efficacy of pharmacologic 
intervention. 
7. Procedure description 
Carotid ultrasound can be performed using vascular echographic apparatus equipped with 
high-frequency transducers (usually 3-10 MHz and linear array) and appropriate software. 
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The patient should be positioned supine with slight (45°) hyperextension and rotation of the 
neck in the direction opposite the probe. 
CCA-IMT is defined as the distance between the lumen-intima interface and the media-
adventitia interface, which corresponds to the inner and outer echogenic lines seen on the B-
mode ultrasound image [see figure 1b] (24,79). 
Measurement of carotid IMT (c-IMT) is traditionally performed with the image of the 
carotid artery in the longitudinal axis, revealing the common carotid artery, the carotid 
bifurcation, and the internal and external carotid arteries.  
Although these measurements have been performed for years, significant variability exists 
when measuring the near wall due to technical and acoustic difficulties encountered when 
imaging the c-IMT of the near wall (80). Due to these technical limitations, clinical 
measurement of c-IMT using B-mode ultrasound is often applied to the far (posterior) wall 
of the common carotid artery. 
IMT is measured at about 2 cm proximal to the dilation of the bulb of the common carotid 
artery. 
Three measurements coming from three different sites [according to the method described 
by Pignoli et al. (79): about 2 cm above the flow-divider, about ½ cm above the flow-divider 
and in middle zone] are considered for IMT evaluation. An average of all these values 
would be calculated at the end of the measures. 
Mean IMT (m-IMT) and maximum IMT (M-IMT) are measured. m-IMT represents the mean 
value of all measurements at each common carotid artery, averaging the left and right sides. 
M-IMT represents the mean value of the single highest IMT measurements at each common 
carotid artery, averaging the left and right sides. Carotid plaque is defined as the presence of 
a greater than 1.5 mm c-IMT measurement or an area within the carotid artery that is at least 
50% greater than the size of the surrounding vessel wall. 
The same physician should perform the evaluation in order to reduce bias and improve the 
results.  
A problem associated with the ultrasonographic IMT measurement is the variation in the 
readings, which leads to different results of repeated measurements from the same observer. 
In general, the inter- and intra-observer errors are acceptable and the technique has a good 
reproducibility (81,82).  
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